Keywords: chiron, submits, nda, pulminiq, biotechnology, major, corp

Chiron submits NDA for Pulminiq

Article | 25 October 2004

Print This

US biotechnology major Chiron Corp has filed a New Drug Application to the US Food and Drug Administration for marketing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in